Erasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 Transcript
Erasca, Inc. presented preliminary Phase I data for its pan-RAS molecular glue candidate ERAS-0015, highlighting early safety, tolerability, and pharmacokinetic profiles. The company emphasized the drug's potential differentiation through its unique mechanism targeting multiple RAS variants. No significant safety concerns were reported in the initial patient cohort. Further clinical development is planned based on these early findings.
- ▪Erasca shared preliminary Phase I data for ERAS-0015, a pan-RAS molecular glue targeting RAS-driven cancers.
- ▪The data included early safety, tolerability, and pharmacokinetic results from a small cohort of patients.
- ▪ERAS-0015 is designed to degrade multiple RAS mutants, differentiating it from other RAS inhibitors.
- ▪No dose-limiting toxicities were observed in the initial dose escalation phase.
- ▪The company plans to advance ERAS-0015 into expanded clinical trials based on the preliminary results.
Full article excerpt tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4894762-erasca-inc-eras-discusses-preliminary-phase-i-data-and-differentiation-of-pan-ras-molecular"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha PRO","url":"https://seekingalpha.com/subscriptions"},{"@type":"Brand","name":"Alpha Picks","url":"https://seekingalpha.com/alpha-picks/subscribe"},{"@type":"Brand","name":"Investing Groups by Seeking Alpha","url":"https://seekingalpha.com/marketplace/directory"}],"contactPoint":{"@type":"ContactPoint","telephone":"+1-347-509-6837","email":"subscriptions@seekingalpha.com"},"description":"Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally.","email":"subscriptions@seekingalpha.com","image":"https://seekingalpha.com/samw/static/images/OrganizationLogo.b472cbb2d.png","foundingDate":"2004","legalName":"Seeking Alpha","logo":{"@type":"ImageObject","height":60,"url":"https://seekingalpha.com/samw/static/images/PublisherLogo.1bcd2753c.png","width":360},"name":"Seeking Alpha","sameAs":["https://www.facebook.com/Seekingalpha","https://www.youtube.com/channel/UC9ZGkLwawKeG5C0Dt9FS-lQ","https://www.linkedin.com/company/seeking-alpha/","https://www.wikidata.org/wiki/Q3477676","https://www.instagram.com/seekingalpha/","https://x.com/SeekingAlpha","https://www.tiktok.com/@seekingalphaofficial","https://open.spotify.com/show/05uLjJxkVgQsRk8LWLCLpx","https://podcasts.apple.com/us/podcast/wall-street-breakfast/id1358381502"],"slogan":"Inform. Empower. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-04-28T02:51:36.000Z","dateModified":"2026-04-28T02:51:37.000Z","description":"Erasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 April 27, 2026 4:30 PM EDTCompany...","headline":"Erasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 Transcript","about":[{"@type":"Corporation","name":"Erasca, Inc.","tickerSymbol":"NASDAQ ERAS","url":"https://seekingalpha.com/symbol/ERAS"}],"image":{"@type":"ImageObject","url":"https://seekingalpha.com/samw/static/images/DefaultArticleImage.7d3405a63.png","height":1200,"width":1200}}TranscriptsErasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 TranscriptApr 27, 2026, 10:51 PM ETErasca, Inc. (ERAS) StockSA Transcripts159.47K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Erasca, Inc. (ERAS) Discusses Preliminary Phase I…
This excerpt is published under fair use for community discussion. Read the full article at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
